Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

TELO

TELO News

Newswire

08:15

Telomir-1 Shows Promise in Reducing PSA Levels in Human Prostate Cancer Cells

07:46

Telomir shares surge 12.95% premarket as Telomir-1 shows preclinical efficacy against leukemia, expanding oncology profile.

07:37

Telomir-1 Shows Promise in Treating Aggressive Prostate Cancer by Resetting Key Defense Systems.

22:19

Biocytogen Pharmaceuticals (2315): Overvalued Amid Mixed Performance and High P/E Ratio

07:38

Telomir Pharmaceuticals Secures Global Rights to Telomir-1, Enhancing Market Potential and Value Growth

View More

About TELO

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More